Government said that by next month, it will come out with a new list of life-saving drugs whose prices would be controlled.
Chemicals and Fertilisers Minister Ananth Kumar said since the new government came to power in May, 175 essential drugs have been added to the list of drugs which are under price control mechanism, taking the number to 615 as 440 were already covered under it.
In the motion, Congress members Ranjeet Ranjan and Susmita Dev accused the government of allowing substantial hike in essential drug prices, including those used for treating cancer, heart ailments, HIV and diabetes.
They attacked the government for the botched up sterlisation cases in Chhattisgarh which had claimed 17 lives recently, saying rise in drug prices as well as easy availability of spurious medicines were the major reasons for this.
To this, Health Minister J P Nadda promised stringent action to prevent such incidents in the future.
While Kumar said 3,000 outlets to sell generic drugs would be opened across the country, Nadda said the government would come out by January with a new list of life-saving drugs whose prices would be controlled.
"In the last six months, the price of no drug or medicine has been hiked" and there is no question of prices skyrocketing, Kumar said, terming it as "misinformation campaign".
"The aim of the government is to ensure good quality and affordable medicines for people," he noted.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
